Advertisement

Table of Contents

May 01, 1995; Volume 47,Issue 5

You have access
Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable ceramides.
A Gomez-Muñoz, P A Duffy, A Martin, L O'Brien, H S Byun, R Bittman and D N Brindley

Molecular Pharmacology May 1995, 47 (5) 833-839;
You have access
Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide.
A Copani, V Bruno, G Battaglia, G Leanza, R Pellitteri, A Russo, S Stanzani and F Nicoletti

Molecular Pharmacology May 1995, 47 (5) 890-897;
You have access
Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
S Lelièvre, Y Benchokroun and A K Larsen

Molecular Pharmacology May 1995, 47 (5) 898-906;
You have access
Camptothecin induction of a time- and concentration-dependent decrease of topoisomerase I and its implication in camptothecin activity.
D R Beidler and Y C Cheng

Molecular Pharmacology May 1995, 47 (5) 907-914;
You have access
Regulation of rat 5-hydroxytryptamine type 2 receptor gene activity: identification of cis elements that mediate basal and 5-hydroxytryptamine-dependent gene activation.
Y L Du, B D Wilcox and J J Jeffrey

Molecular Pharmacology May 1995, 47 (5) 915-922;
You have access
Vasoactive intestinal peptide elevates pinealocyte intracellular calcium concentrations by enhancing influx: evidence for involvement of a cyclic GMP-dependent mechanism.
N C Schaad, J Vanecek, I R Rodriguez, D C Klein, L Holtzclaw and J T Russell

Molecular Pharmacology May 1995, 47 (5) 923-933;
You have access
Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
S Chen, R Knox, A D Lewis, F Friedlos, P Workman, P S Deng, M Fung, D Ebenstein, K Wu and T M Tsai

Molecular Pharmacology May 1995, 47 (5) 934-939;
You have access
Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6.
J Q Chen, A Ström, J A Gustafsson and E T Morgan

Molecular Pharmacology May 1995, 47 (5) 940-947;
You have access
GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis.
C V Catapano, J S Dayton, B S Mitchell and D J Fernandes

Molecular Pharmacology May 1995, 47 (5) 948-955;
You have access
Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping.
R A Vaughan

Molecular Pharmacology May 1995, 47 (5) 956-964;
You have access
Interaction of dolastatin 10 with tubulin: induction of aggregation and binding and dissociation reactions.
R Bai, G F Taylor, J M Schmidt, M D Williams, J A Kepler, G R Pettit and E Hamel

Molecular Pharmacology May 1995, 47 (5) 965-976;
You have access
Cloning of the human alpha 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells.
T A Esbenshade, A Hirasawa, G Tsujimoto, T Tanaka, J Yano, K P Minneman and T J Murphy

Molecular Pharmacology May 1995, 47 (5) 977-985;
You have access
Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosis.
H M Beere, C M Chresta, A Alejo-Herberg, A Skladanowski, C Dive, A K Larsen and J A Hickman

Molecular Pharmacology May 1995, 47 (5) 986-996;
You have access
Gi is involved in ethanol inhibition of L-type calcium channels in undifferentiated but not differentiated PC-12 cells.
D Mullikin-Kilpatrick, N D Mehta, J D Hildebrandt and S N Treistman

Molecular Pharmacology May 1995, 47 (5) 997-1005;
You have access
Flufenamic and tolfenamic acids inhibit calcium influx in human polymorphonuclear leukocytes.
H Kankaanranta and E Moilanen

Molecular Pharmacology May 1995, 47 (5) 1006-1013;
You have access
Blockade of capacitive Ca2+ influx by Cl- channel blockers inhibits secretion from rat mucosal-type mast cells.
M Reinsprecht, M H Rohn, R J Spadinger, I Pecht, H Schindler and C Romanin

Molecular Pharmacology May 1995, 47 (5) 1014-1020;
You have access
Metabolism and cytotoxicity of propyl gallate in isolated rat hepatocytes: effects of a thiol reductant and an esterase inhibitor.
Y Nakagawa, K Nakajima, S Tayama and P Moldéus

Molecular Pharmacology May 1995, 47 (5) 1021-1027;
You have access
Free radical adducts in the bile of rats treated chronically with intragastric alcohol: inhibition by destruction of Kupffer cells.
K T Knecht, Y Adachi, B U Bradford, Y Iimuro, M Kadiiska, Q H Xuang and R G Thurman

Molecular Pharmacology May 1995, 47 (5) 1028-1034;
You have access
kappa-Opioid receptor activates an inwardly rectifying K+ channel by a G protein-linked mechanism: coexpression in Xenopus oocytes.
G H Ma, R J Miller, A Kuznetsov and L H Philipson

Molecular Pharmacology May 1995, 47 (5) 1035-1040;
You have access
Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
E T Piros, P L Prather, H H Loh, P Y Law, C J Evans and T G Hales

Molecular Pharmacology May 1995, 47 (5) 1041-1049;
You have access
[3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
C Labbé-Jullié, J M Botto, M V Mas, J Chabry, J Mazella, J P Vincent, D Gully, J P Maffrand and P Kitabgi

Molecular Pharmacology May 1995, 47 (5) 1050-1056;
You have access
Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-D-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro.
A Ambrosini, L Bresciani, S Fracchia, N Brunello and G Racagni

Molecular Pharmacology May 1995, 47 (5) 1057-1064;
You have access
Residue 78 in the second transmembrane domain of the neurokinin-1 receptor is important in coupling high affinity agonist binding to multiple second messenger responses.
R M Brodbeck, B S Sachais and J E Krause

Molecular Pharmacology May 1995, 47 (5) 1065-1071;
You have access
Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
L Y Yang, L Li, M J Keating and W Plunkett

Molecular Pharmacology May 1995, 47 (5) 1072-1079;
You have access
Tissue-specific pharmacology of testosterone and 5 alpha-dihydrotestosterone analogues: characterization of a novel canine liver androgen-binding protein.
A E Summerfield, P J Diaz Cruz, M P Dolenga, H E Smith, C D Strader and J H Toney

Molecular Pharmacology May 1995, 47 (5) 1080-1088;